ASX:CVS Cervantes (CVS) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free CVS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cervantes alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About Cervantes Stock (ASX:CVS)Cervantes Corporation Limited engages in the exploration and evaluation of mineral resource projects in Australia. The company primarily explores for gold, as well as for nickel, cobalt, and base metals. It holds interests in the Primrose project located in the Murchison District of the Eastern Goldfields, Western Australia. Cervantes Corporation Limited was incorporated in 2001 and is headquartered in South Perth, Australia.Read More Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). CVS Stock News HeadlinesMarch 29, 2024 | yahoo.comIs Publix open on Easter 2024? Here’s what’s open and closed on SundayFebruary 11, 2024 | news.yahoo.comSenate passes bill for 7-day waiting period on gun buysApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.December 2, 2023 | usatoday.comAuthor Luis Mateo Díez wins Cervantes Prize, the Spanish-speaking world's top literary honorOctober 27, 2023 | usatoday.comCVS walkout ends; pharmacists cautiously optimistic amid promises of more staff and reliefOctober 17, 2023 | msn.comCHP: California woman rescued after SUV drove into San Joaquin River has diedOctober 13, 2023 | health.usnews.comJosie D. CervantesOctober 3, 2023 | latimes.comCVS Photo Coupon | October 2023April 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.August 2, 2023 | uk.finance.yahoo.comCVS - CVS Health CorporationJune 2, 2023 | health.usnews.comDr. Victoria CervantesMay 3, 2023 | uk.finance.yahoo.comCVS Health Corporation (CVS) stock price, news, quote & history – Yahoo FinanceFebruary 24, 2023 | usatoday.comWant to try natural deodorant? Native deodorant is Reviewed-approved and on sale at CVSFebruary 21, 2023 | usatoday.comKick-start your spring cleaning with CVS deals on Swiffer, Febreze and moreJanuary 16, 2023 | cbsnews.comCVS sued by nurse who was fired after she refused to prescribe birth control because of her religious beliefsAugust 24, 2022 | finance.yahoo.comThe Good, Bad & Kinda Weird Exercises People Try On TikTokAugust 9, 2022 | investing.comNYSE Tick Index (TIC.N)August 5, 2022 | ca.finance.yahoo.comTreace Announces Full Commercial Release of New Technologies for Bunion and Related Midfoot SurgeryJune 7, 2022 | finance.yahoo.comI have Alzheimer’s. Don’t feel sorry for me | GuestviewMay 29, 2022 | finance.yahoo.comAffimed Highlights Trial Designs of Three AFM24 Ongoing Clinical Studies at the Annual Meeting of the American Society of Clinical Oncology (ASCO)May 1, 2022 | msn.comDEA National Take Back Saturday: Here's where you can dispose old prescriptionsMarch 25, 2022 | proactiveinvestors.com.auReach Resources gets new CEO as it moves to become significant player in emerging circular economyFebruary 12, 2022 | msn.comUPDATE: 22-year-old man arrested for robbing Pensacola CVS at gunpointFebruary 12, 2022 | au.finance.yahoo.comUPDATE 3-CVS forecasts COVID vaccine business drop of up to 80% in 2022February 10, 2022 | msn.comMan in custody after Pensacola armed robberyFebruary 10, 2022 | yahoo.comPPD: Police searching for armed suspect who robbed CVSFebruary 10, 2022 | msn.comSuspect arrested in early morning armed robbery at CVSSee More Headlines Receive CVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cervantes and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2018Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Gold Sub-IndustryN/A Current SymbolASX:CVS CUSIPN/A CIKN/A Webwww.cervantescorp.com.au Phone+61-8-64362300FaxN/AEmployees2,020Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio13.00 Current Ratio4.21 Quick Ratio4.21 Sales & Book Value Annual Sales$29,654.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.11 Book ValueA$0.00 per share Price / BookN/AMiscellaneous Outstanding Shares1,554,009,984Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Justin Vost (Age 50)Consultant Comp: $40kMr. Marcus F. Flis BSc (Hons) (Age 63)M.Sc., FAusIMM, Exploration Mang. & Non-Exec. Director Comp: $22.55kMr. Christopher Achurch B.Com.C.A., Company Sec.Key CompetitorsAben MineralsOTCMKTS:ABNAFAdelong GoldASX:ADGAlacer GoldOTCMKTS:ALIAFALACERGOLD/IDR UNRESTRASX:AQGAlchemy ResourcesASX:ALYView All Competitors CVS Stock Analysis - Frequently Asked Questions How were Cervantes' earnings last quarter? Cervantes Co. Limited (ASX:CVS) released its quarterly earnings data on Wednesday, March, 14th. The company reported $0.00 earnings per share for the quarter. What other stocks do shareholders of Cervantes own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cervantes investors own include Consumer Staples Select Sector SPDR Fund (XLP), RiverFront Dynamic US Flex-Cap ETF (RFFC), RiverFront Dynamic US Dividend Advantage ETF (RFDA), First Trust RiverFront Dynamic Developed International ETF (RFDI), ALPS ETF Trust - Riverfront Dynamic Unconstrained Income ETF (RFUN), Financial Select Sector SPDR Fund (XLF), iShares Core S&P Small-Cap ETF (IJR), PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund (HYS). This page (ASX:CVS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarningsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersI’m afraid WWIII is a very real possibility Porter & CompanyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cervantes Co. Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
